Compare CDNA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | MMI |
|---|---|---|
| Founded | 1998 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2007 | 2013 |
| Metric | CDNA | MMI |
|---|---|---|
| Price | $17.75 | $26.83 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | $27.33 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 591.0K | 299.1K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | N/A | ★ 84.38 |
| EPS | N/A | ★ N/A |
| Revenue | $48,324,000.00 | ★ $719,700,000.00 |
| Revenue This Year | $15.37 | $14.04 |
| Revenue Next Year | $11.23 | $11.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $24.43 |
| 52 Week High | $21.49 | $36.70 |
| Indicator | CDNA | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 56.08 |
| Support Level | $16.74 | $24.89 |
| Resistance Level | $18.02 | $27.32 |
| Average True Range (ATR) | 0.85 | 0.89 |
| MACD | -0.13 | 0.14 |
| Stochastic Oscillator | 23.20 | 91.18 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.